SILVARA BIO Trademark

Trademark Overview


On Friday, May 2, 2025, a trademark application was filed for SILVARA BIO with the United States Patent and Trademark Office. The USPTO has given the SILVARA BIO trademark a serial number of 99166977. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Sunday, September 28, 2025. This trademark is owned by Electra Therapeutics, Inc.. The SILVARA BIO trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical research and development; Pharmaceutical products development
silvara bio

General Information


Serial Number99166977
Word MarkSILVARA BIO
Filing DateFriday, May 2, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateSunday, September 28, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical research and development; Pharmaceutical products development

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, May 2, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameElectra Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Friday, May 2, 2025APPLICATION FILING RECEIPT MAILED
Friday, September 12, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sunday, September 21, 2025ASSIGNED TO EXAMINER
Friday, May 2, 2025NEW APPLICATION ENTERED
Sunday, September 28, 2025NON-FINAL ACTION E-MAILED
Sunday, September 28, 2025NON-FINAL ACTION WRITTEN
Sunday, September 28, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED